Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.
Tanaka Y, Manabe A, Fukushima H, Suzuki R, Nakadate H, Kondoh K, Nakamura K, Koh K, Fukushima T, Tsuchida M, Koike K, Kiyokawa N, Noguchi E, Sumazaki R, Komiyama T. Tanaka Y, et al. Pharmacogenomics J. 2015 Aug;15(4):380-4. doi: 10.1038/tpj.2014.74. Epub 2014 Nov 18. Pharmacogenomics J. 2015. PMID: 25403995
[Pharmacogenomics for leukemia treatment].
Tanaka Y. Tanaka Y. Rinsho Ketsueki. 2016 Jul;57(7):910-8. doi: 10.11406/rinketsu.57.910. Rinsho Ketsueki. 2016. PMID: 27498738 Japanese.
Regional evaluation of childhood acute lymphoblastic leukemia genetic susceptibility loci among Japanese.
Urayama KY, Takagi M, Kawaguchi T, Matsuo K, Tanaka Y, Ayukawa Y, Arakawa Y, Hasegawa D, Yuza Y, Kaneko T, Noguchi Y, Taneyama Y, Ota S, Inukai T, Yanagimachi M, Keino D, Koike K, Toyama D, Nakazawa Y, Kurosawa H, Nakamura K, Moriwaki K, Goto H, Sekinaka Y, Morita D, Kato M, Takita J, Tanaka T, Inazawa J, Koh K, Ishida Y, Ohara A, Mizutani S, Matsuda F, Manabe A. Urayama KY, et al. Among authors: tanaka t, tanaka y. Sci Rep. 2018 Jan 15;8(1):789. doi: 10.1038/s41598-017-19127-7. Sci Rep. 2018. PMID: 29335448 Free PMC article.
Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.
Huang M, Inukai T, Miyake K, Tanaka Y, Kagami K, Abe M, Goto H, Minegishi M, Iwamoto S, Sugihara E, Watanabe A, Somazu S, Shinohara T, Oshiro H, Akahane K, Goi K, Sugita K. Huang M, et al. Among authors: tanaka y. Cancer Med. 2018 Apr;7(4):1297-1316. doi: 10.1002/cam4.1323. Epub 2018 Feb 23. Cancer Med. 2018. PMID: 29473342 Free PMC article.
15,356 results
You have reached the last available page of results. Please see the User Guide for more information.